Emergency care systems are challenged by the emergence of an ageing population, requiring tailored inputs facilitated by early care needs assessment. We examined the potential of Machine Learning algorithms to identify in-hospital healthcare contacts…
Continue Reading
Effective risk stratification is essential in clinical practice, enabling better resource allocation and improved patient outcomes. Although machine learning models have been widely used for risk prediction and stratification in electronic health record (EHR)…
Continue Reading
Grade 2 subclinical hypothyroidism (G2SCH) is associated with an increased risk of various diseases but is rarely detected before symptom onset. This study aims to develop a machine learning-based prediction model for G2SCH using…
Continue Reading
Globally, drug discovery and development programs are complex, multi-decade long and prohibitively expensive. Artificial intelligence (AI) and other digital health technologies have the potential to enhance and accelerate each stage of drug discovery and…
Continue Reading
Prostate cancer (PCa) ranks among the most prevalent cancers in men worldwide. Biochemical recurrence (BCR) presents a major clinical challenge in PCa management, with significant prognostic heterogeneity observed among patients post-recurrence. This study aimed…
Continue Reading
Endovascular aortoiliac revascularization is a common treatment option for peripheral artery disease that carries non-negligible risks. Outcome prediction tools may support clinical decision-making but remain limited. We developed machine learning algorithms that predict 30-day…
Continue Reading
What is Epic’s Augmented Response Technology?
Epic’s Augmented Response Technology (ART) is a sophisticated generative AI system designed to transform patient-provider communication through MyChart messaging platforms. The Spanish-language version of this innovative tool represents the…
The Acute Respiratory Illness Surveillance (AcRIS) Study was a low-interventional trial that examined voice changes with respiratory illnesses. This longitudinal trial was the first of its kind, conducted in a fully decentralized manner via…
Continue Reading
Biotechnology and precision medicine company Caris Life Sciences announced it raised $168 million in growth capital funding.Caris Life Sciences has now raised $1.86 billion in capital since 2018.
Braidwell LP led the round with participation…
Now that AI tools are everywhere, the question making headlines is whether businesses will see substantial returns from their AI investments. The answer for health plans is a definite yes. Health plans are using…
Continue Reading
